Shipments of Pfizer’s coronavirus vaccine are scheduled for arrival in the United States on Dec. 15, according to White House documents. – By Gerald Gekara and News Agencies.
The US Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on Dec. 10 to consider authorizing Pfizer’s vaccine.
The document has listed a four-day window between Dec. 11 and Dec. 14 for review by the FDA and CDC’s Advisory Committee on Immunization Practices. On Dec. 15, the first doses of Pfizer’s coronavirus vaccine will be delivered, according to the outline.
Next, the VRBPAC is scheduled to consider Moderna’s vaccine on Dec. 17. After a four-day review window from Dec. 18 to Dec. 21, the document states that the first shipments of Moderna’s vaccine are estimated to be delivered on Dec. 22.
The document includes a vaccine manufacturing forecast, estimating 22.5 million doses of the Pfizer vaccine and 18 million doses of the Moderna vaccine will be manufactured in December.
A list of “essential tasks” is included for governors to complete by Dec. 4, including pre-ordering Pfizer vaccines, enrolling providers in the Covid-19 vaccine program and completing microplans for distribution and administration.
